Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Lung Surgery

NCT02960971 is registered in ClinicalTrials.gov with Danish Pain Research Center as lead sponsor.

NCT NCT02960971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02960971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Lung Surgery
Lead sponsor
Danish Pain Research Center
Phase
Observational
Overall status
Completed
Start date
January 2, 2017
Completion date
June 16, 2021
Enrollment
78 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic chemotherapy-induced neuropathic pain, chronic chemotherapy-induced pain, chronic chemotherapy-induced peripheral neuropathy, chronic neuropathic pain, postoperative, chronic pain, postoperative